In vivo CRISPR screening identifies BAZ2 chromatin remodelers as druggable regulators of mammalian liver regeneration.
In vivo CRISPR screening identifies BAZ2 chromatin remodelers as druggable regulators of mammalian liver regeneration.
复制标题
DOI:
10.1016/j.stem.2022.01.001
复制
发表时间:
2022-03-03
期刊:
影响因子:
23.9
通讯作者:
Zhu H
中科院分区:
文献类型:
--
作者:
Jia Y;Li L;Lin YH;Gopal P;Shen S;Zhou K;Yu X;Sharma T;Zhang Y;Siegwart DJ;Ready JM;Zhu H
Identifying new pathways that regulate mammalian regeneration is challenging due to the paucity of in vivo screening approaches. We employed pooled CRISPR knockout and activation screening in the regenerating liver to evaluate 165 chromatin regulatory proteins. Both screens identified imitation-SWI chromatin remodeling components Baz2a and Baz2b, not previously implicated in regeneration. In vivo sgRNA, siRNA, and knockout strategies against either paralog confirmed increased regeneration. Distinct BAZ2-specific bromodomain inhibitors GSK2801 and BAZ2-ICR resulted in accelerated liver healing after diverse injuries. Inhibitor treated mice also exhibited improved healing in an inflammatory bowel disease model, suggesting multi-tissue applicability. Transcriptomics on regenerating livers showed increases in ribosomal and cell cycle mRNAs. Surprisingly, CRISPRa screening to define mechanisms showed that overproducing Rpl10a or Rpl24 was sufficient to drive regeneration, while Rpl24 haploinsufficiency was rate limiting for BAZ2 inhibition mediated regeneration. The discovery of regenerative roles for imitation-SWI components provides immediate strategies to enhance tissue repair. New regulators of tissue regeneration are challenging to identify in mammalian models. Here, pooled in vivo CRISPR screening in the liver identified imitation-SWI chromatin remodeling components Baz2a and Baz2b as regeneration suppressors. BAZ2-specific bromodomain inhibitors resulted in accelerated liver and intestinal healing, effects mediated through increased protein synthesis during regeneration.
登录
查看更多内容
DOI:
10.1093/bioinformatics/btu638
发表时间:
2015-01-15
期刊:
Bioinformatics (Oxford, England)
影响因子:
--
作者:
Anders S;Pyl PT;Huber W
通讯作者:
Huber W
DOI:
10.15252/embj.2020105606
发表时间:
2020-12-01
期刊:
The EMBO journal
影响因子:
--
作者:
Dalcher D;Tan JY;Bersaglieri C;Peña-Hernández R;Vollenweider E;Zeyen S;Schmid MW;Bianchi V;Butz S;Roganowicz M;Kuzyakiv R;Baubec T;Marques AC;Santoro R
通讯作者:
Santoro R
影响因子:
30.8
作者:
GROMPE, M;LINDSTEDT, S;FINEGOLD, M
通讯作者:
FINEGOLD, M
影响因子:
7.2
作者:
Liang, Roger;Lin, Yu-Hsuan;Zhu, Hao
通讯作者:
Zhu, Hao
影响因子:
64.8
作者:
Blanco, Sandra;Bandiera, Roberto;Popis, Martyna;Hussain, Shobbir;Lombard, Patrick;Aleksic, Jelena;Sajini, Abdulrahim;Tanna, Hinal;Cortes-Garrido, Rosana;Gkatza, Nikoletta;Dietmann, Sabine;Frye, Michaela
通讯作者:
Frye, Michaela